Iwona Misztalewska-Turkowicz Selected Research

acetylacetone

1/2022

Doxorubicin delivery systems with an acetylacetone-based block in cholesterol-terminated copolymers: Diverse activity against estrogen-dependent and estrogen-independent breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iwona Misztalewska-Turkowicz Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2021
2	Neoplasms (Cancer) 01/2022 - 05/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Endotoxemia 02/2019
1	Bacterial Infections (Bacterial Infection) 02/2019
1	Inflammation (Inflammations) 02/2019

Drug/Important Bio-Agent (IBA)

2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2021
2	CholesterolIBA 01/2022 - 05/2021
1	Estrogens (Estrogen)FDA Link 01/2022
1	acetylacetoneIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	acrylic acid (acrylate)IBA 05/2021
1	Biological ProductsIBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 02/2019
1	GoldIBA 02/2019
1	Peptides (Polypeptides)IBA 02/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2019
1	GelsolinIBA 02/2019
1	ferric oxide (iron oxide)IBA 02/2019

Therapy/Procedure

2	Therapeutics 05/2021 - 02/2019
1	Drug Therapy (Chemotherapy) 05/2021